| Authors: |
Vijayakumar S; Amyloidosis Program, Brigham and Women's Hospital, Boston, USA; Division of Nuclear Medicine and Molecular Imaging, Brigham and Women's Hospital, Boston, USA., Pabon AR; Amyloidosis Program, Brigham and Women's Hospital, Boston, USA; Division of Nuclear Medicine and Molecular Imaging, Brigham and Women's Hospital, Boston, USA., Clerc OF; Amyloidosis Program, Brigham and Women's Hospital, Boston, USA; Division of Nuclear Medicine and Molecular Imaging, Brigham and Women's Hospital, Boston, USA., Cuddy SAM; Amyloidosis Program, Brigham and Women's Hospital, Boston, USA; Division of Nuclear Medicine and Molecular Imaging, Brigham and Women's Hospital, Boston, USA., Gu Y; Amyloidosis Program, Brigham and Women's Hospital, Boston, USA; Division of Nuclear Medicine and Molecular Imaging, Brigham and Women's Hospital, Boston, USA., Watts C; Amyloidosis Program, Brigham and Women's Hospital, Boston, USA; Division of Nuclear Medicine and Molecular Imaging, Brigham and Women's Hospital, Boston, USA., Sullivan K; Division of Nuclear Medicine and Molecular Imaging, Brigham and Women's Hospital, Boston, USA., Auer B; Division of Nuclear Medicine and Molecular Imaging, Brigham and Women's Hospital, Boston, USA., Kijewski MF; Division of Nuclear Medicine and Molecular Imaging, Brigham and Women's Hospital, Boston, USA., DiCarli MF; Division of Nuclear Medicine and Molecular Imaging, Brigham and Women's Hospital, Boston, USA., Falk RH; Amyloidosis Program, Brigham and Women's Hospital, Boston, USA; Division of Nuclear Medicine and Molecular Imaging, Brigham and Women's Hospital, Boston, USA., Dorbala S; Amyloidosis Program, Brigham and Women's Hospital, Boston, USA; Division of Nuclear Medicine and Molecular Imaging, Brigham and Women's Hospital, Boston, USA. Electronic address: sdorbala@bwh.harvard.edu. |